Summary
First report on nine patients suffering from psoriasis who were treated with somatostatin or bromocriptin or both. These are inhibitors of HGH. The therapeutical effect on skin lesions and psoriatic alterations to joints is described.
Zusammenfassung
Bericht über neun Psoriasis-Patienten, die mit Somatostatin und/oder Bromocriptin, Hemmern des menschlichen Wachstumshormons, behandelt wurden. Die therapeutische Wirkung auf Hauterscheinungen und psoriatische Gelenkbeschwerden wird mitgeteilt.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Weber G (1980) Aetiology of psoriasis, persistence of human growth hormone, Eur Soc Dermatol Res, Amsterdam, May 14th
Weber G, Neidhardt M (1980) Korrelation zwischen Psoriasis und menschlichem Wachstumshormon. Münch Med Wochenschr 122:47: 1690–1694
Weber G (1980) Werwendung eines Mittels zur Behandlung der Psoriasis. Deutsches Patentamt 6.5
Schusdziarra V, Harris V, Unger RH (1979) Half-life of somatostatin-like immunoreactivity in canine plasma. Endocrinology 104:109–110
Keller U (1979) Somatostatin. Therap Umschau 36:10:873–881
Weber G, Neidhardt M, Schmidt A, Geiger A (1981) Korrelation von Wachstumshormon und klinischem Bild der Psoriasis. Arch Dermatol Res (in press)
Author information
Authors and Affiliations
Additional information
Dedicated to Professor H. Oberste-Lehn on his 60th birthday
The research was kindly supported by Kabi Vitrum, Sweden and Kabi Vitrum, FRG
Rights and permissions
About this article
Cite this article
Weber, G., Klughardt, G. & Neidhardt, M. Psoriasis and human growth hormone: Aetiology and therapy. Arch Dermatol Res 270, 361–365 (1981). https://doi.org/10.1007/BF00403941
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00403941